Hola,
¿eres nuevo aquí?

Registrate y conecta tu empresa con financiación pública, partners y proyectos.

GRIP

Financiado

reGeneRative bone Implant for the treatment of hip dysPlasia

GRIP develops a personalised, 3D-printed regenerative bone implant as a treatment for hip instability (hip dysplasia) and its commercialisation strategy. Osteoarthritis (OA) of the hip is a painful and debilitating condition and h... ver más

31/01/2024

UMC UTRECHT

150K€

Presupuesto del proyecto: 150K€

Líder del proyecto

UNIVERSITAIR MEDISCH CENTRUM UTRECHT No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Financiación concedida El organismo HORIZON EUROPE notifico la concesión del proyecto el día 2024-01-31

Línea de financiación objetivo El proyecto se financió a través de la siguiente ayuda:

ERC-2022-POC1: ERC PROOF OF CONCEPT GRANTS1

I+D

Cerrada hace 3 años

0% 100% 100%

1 Participantes

UMC UTRECHT

150.00K€ | Lider

Proyectos interesantes

JointPrinting 3D Printing of Cell Laden Biomimetic Materials and Biomolecu... 2M€ Cerrado

PID2021-126471OA-I00 DISEÑO OPTIMO DE PROTESIS DE CADERA CON ESTRUCTURAS POROSAS... 112K€ Cerrado

ReCaP Regeneration of Articular Cartilage using Advanced Biomateri... 3M€ Cerrado

ANCHOR Articular cartilage regeneration through the recruitment of... 150K€ Cerrado

REGENERBONE REGENERATING LARGE BONE DEFECTS 150K€ Cerrado

MEMS Melt Electrowriting of Multi-layered Scaffolds for osteochon... 150K€ Cerrado

Últimas noticias

30-11-2024: Cataluña Gestión For... Se ha cerrado la línea de ayuda pública: Gestión Forestal Sostenible para Inversiones Forestales Productivas para el organismo:

29-11-2024: IDAE En las últimas 48 horas el Organismo IDAE ha otorgado 4 concesiones

29-11-2024: ECE En las últimas 48 horas el Organismo ECE ha otorgado 2 concesiones

Duración del proyecto: 18 meses Fecha Inicio: 2022-07-04
Fecha Fin: 2024-01-31

Líder del proyecto

UNIVERSITAIR MEDISCH CENTRUM UTRECHT

TRL 4-5

Presupuesto del proyecto 150K€

Descripción del proyecto GRIP develops a personalised, 3D-printed regenerative bone implant as a treatment for hip instability (hip dysplasia) and its commercialisation strategy. Osteoarthritis (OA) of the hip is a painful and debilitating condition and hip dysplasia is one of the two main causes. The currently most common surgical methods to correct the dysplasia involve the re-alignment of the hip socket (osteotomy) or the insertion of a bone graft to enlarge the socket (shelf arthroplasty). While the osteotomy is invasive, the shelf arthroplasty requires donor tissue. In addition, both procedures only have limited success rates. GRIP implants overcome the current shortcomings of these methods and provide a novel personalized implant to treat hip dysplasia. GRIP will provide patients and surgeons with an easy to use, one-step and cost-effective regenerative device, therefore overcoming the significant drawbacks with current treatments for hip dysplasia. The GRIP implants will be precisely fabricated from a flexible bone-inducing biomaterial through a process both developed and established within the ERC-CoG 3D-JOINT project. This will ensure a perfect fit, resulting in optimal integration and durable restoration of the hip socket, as well as obviating the need for complex and invasive osteotomy surgeries. GRIP implants will revolutionise the treatment of hip dysplasia as they provide a stable, long-term, and regenerative solution that will fully integrate with the host bone tissue. Moreover, the regenerative nature will also make this a potential treatment option for younger (paediatric) patients. As GRIP will transform the treatment of hip dysplasia and will improve long-term health and well-being of both human and veterinary patients the economic value and the route to the market for the GRIP technologies will be explored.

Conecta tu I+D

Entra hoy

Financiación

Empresas

CTIs/Universidades

Proyectos

Investigadores